Pattison, M. | Search bioRxiv

bioRxiv2022

p38γ and p38δ modulate innate immune response by regulating MEF2D activation

Evidence implicating p38{gamma} and p38{delta} (p38{gamma}/p38{delta}) in inflammation are mainly based on experiments using p38{gamma}/p38{delta} deficient (p38{gamma}/{delta}-/-) mice, which show low levels of TPL2, the kinase upstream of MKK1-ERK1/2 in myeloid cells. This could obscure p38{gamma}/p38{delta} roles, since TPL2 is essential for regulating inflammation. Here we generated a p38{gamma}D171A/D171A/p38{delta}-/- (p38{gamma}/{delta}KIKO) mouse, expressing kinase-inactive p38{gamma} and lacking p38{delta}. This mouse exhibited normal TPL2 levels, making it an excellent tool to elucidate specific p38{gamma}/p38{delta} functions. p38{gamma}/{delta}KIKO mice showed a reduced inflammatory response and less susceptibility to LPS-induced septic shock and Candida albicans infection than wild-type mice. Gene expression analyses in LPS-activated WT and p38{gamma}/{delta}KIKO macrophages revealed that p38{gamma}/p38{delta} regulated numerous genes implicated in innate immune response. Additionally, phospho-proteomic analyses and in vitro kinase assays showed that the transcription factor myocyte enhancer factor-2D (MEF2D) was phosphorylated at Ser444 via p38{gamma}/p38{delta}. Mutation of MEF2D Ser444 to the non-phosphorylatable residue Ala increased its transcriptional activity and the expression of iNOS and IL-1{beta} mRNA. These results suggest that p38{gamma}/p38{delta} govern innate immune responses by regulating MEF2D phosphorylation and transcriptional activity.

molecular biology↗

bioRxiv2020

ARDS and Cytokine Storm in SARS-CoV-2 Infected Caribbean Vervets

SARS-CoV-2 induces a wide range of disease severity ranging from asymptomatic infection, to a life-threating illness, particularly in the elderly and persons with comorbid conditions. Among those persons with serious COVID-19 disease, acute respiratory distress syndrome (ARDS) is a common and often fatal presentation. Animal models of SARS-CoV-2 infection that manifest severe disease are needed to investigate the pathogenesis of COVID-19 induced ARDS and evaluate therapeutic strategies. Here we report ARDS in two aged African green monkeys (AGMs) infected with SARS-CoV-2 that demonstrated pathological lesions and disease similar to severe COVID-19 in humans. We also report a comparatively mild COVID-19 phenotype characterized by minor clinical, radiographic and histopathologic changes in the two surviving, aged AGMs and four rhesus macaques (RMs) infected with SARS-CoV-2. We found dramatic increases in circulating cytokines in three of four infected, aged AGMs but not in infected RMs. All of the AGMs showed increased levels of plasma IL-6 compared to baseline, a predictive marker and presumptive therapeutic target in humans infected with SARS-CoV-2 infection. Together, our results show that both RM and AGM are capable of modeling SARS-CoV-2 infection and suggest that aged AGMs may be useful for modeling severe disease manifestations including ARDS.

pathology↗